No Data
No Data
Does This Valuation Of Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (SHSE:688212) Imply Investors Are Overpaying?
Aohua Endoscopy (688212.SH): received government subsidy of 14.15 million yuan
On October 8, GeLongHui reported that Aohua Endoscopy (688212.SH) announced that on September 30, 2024, the company received a total of RMB 14.15 million in government subsidy funds, all of which are government grants related to income.
Aohua Endoscopy (688212.SH): Some senior executives plan to increase their shareholding in the company by no more than 6.2 million yuan.
On September 22nd, Gelonhui announced that the company recently received letters from the Vice General Manager and Secretary of the Board of Directors, Shi Xiaojiang, Vice General Manager Chen Peng, Vice General Manager Bao Hanjing, and Vice General Manager Wang Xiguang. Based on their confidence in the company's future stable development and recognition of the long-term investment value of the company's stocks, they plan to increase their shareholding in the company through the methods allowed by the Shanghai Stock Exchange system (including but not limited to centralized bidding, block trades, etc.) within 6 months starting from September 23, 2024. The total amount of the shareholding increase shall not be less than 3.7 million yuan (inclusive) and shall not exceed 6.2 million yuan.
Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Might Be Having Difficulty Using Its Capital Effectively
Aohua Endoscopy (688212.SH): Appalachian plans to reduce its shareholding in the company by no more than 1.42%.
Australia Hua Endoscope (688212.SH) announced that Appalachian plans to use centralized bidding and bulk...
Half-year report for the year 2024.
No Data
No Data